
Tech-Powered, Expert-Led, and Ready to Scale - SteelSky Ventures Invests in Posterity Health to Transform Fertility Care
- Editor
- Feb 19
- 1 min read
Whats Happening:
SteelSky Ventures, a leading women's health fund, has made a strategic investment in Posterity Health, a technology-driven platform focused on optimizing male fertility care. This investment aims to improve fertility outcomes and reduce costs associated with traditional fertility treatments by addressing male fertility early in the process.
Key Moves:
SteelSky Ventures invests in Posterity Health to transform male fertility care
Posterity Health offers AI-driven diagnostics, telehealth, and at-home testing
The platform aims to reduce the need for expensive and intrusive IVF treatments
By The Numbers:
50% of infertility cases are male-driven
Average IVF success rate is 30% per cycle
Each failed IVF cycle costs $15,000 to $25,000
Key Quotes:
"For decades, women have shouldered the burden of fertility treatment. Posterity Health shifts the conversation ensuring that both partners are actively involved in the journey," said Maria D. Toler, Managing Partner at SteelSky Ventures.
"Women's health doesn't exist in a silo," said Casey Albert, Partner at SteelSky Ventures. "By prioritizing male fertility, Posterity Health is redefining what comprehensive evidence-based reproductive care should be."
"Posterity Health is uniquely positioned to provide world-class fertility care through the leading specialists in the country. Our goal is to become the trusted partner for the male reproductive journey," said Pam Pure, CEO of Posterity Health.
Bottom Line:
SteelSky Ventures' investment in Posterity Health represents a significant step towards a more holistic and cost-effective approach to fertility care. By focusing on male fertility early in the process, this partnership aims to improve overall outcomes, reduce the need for expensive treatments, and transform the reproductive healthcare journey for couples.



Comments